Nuzenio

Chiesi

Chiesi news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 6 publisher sources 100/100 entity strength

Latest news

NHS England backs Procysbi for ultra-rare nephropathic cystinosis - The Pharma LetterThe Pharma Letter · Wed, 05 Aug 2026 12:17:43 GMTCary company ends $160M drug collaboration - The Business JournalsThe Business Journals · Thu, 30 Jul 2026 11:17:00 GMTChiesi retreats from Gossamer PAH programme after Phase 3 miss - European Biotechnology MagazineEuropean Biotechnology Magazine · Tue, 28 Jul 2026 07:00:00 GMTGossamer Reacquires Global Seralutinib Rights From Chiesi, Receives $5 Million - TradingViewTradingView · Mon, 27 Jul 2026 20:03:04 GMTAfter missed endpoint, Gossamer and Chiesi pull the plug on PAH drug collaboration - fiercebiotech.comfiercebiotech.com · Mon, 27 Jul 2026 07:00:00 GMTGossamer regains rights to lung disease asset from Chiesi after Phase 3 fail - BioSpaceBioSpace · Mon, 27 Jul 2026 07:00:00 GMT

Timeline

Wed, 05 Aug 2026 12:17:43 GMTNHS England backs Procysbi for ultra-rare nephropathic cystinosis - The Pharma Letter
Thu, 30 Jul 2026 11:17:00 GMTCary company ends $160M drug collaboration - The Business Journals
Tue, 28 Jul 2026 07:00:00 GMTChiesi retreats from Gossamer PAH programme after Phase 3 miss - European Biotechnology Magazine
Mon, 27 Jul 2026 20:03:04 GMTGossamer Reacquires Global Seralutinib Rights From Chiesi, Receives $5 Million - TradingView
Mon, 27 Jul 2026 07:00:00 GMTAfter missed endpoint, Gossamer and Chiesi pull the plug on PAH drug collaboration - fiercebiotech.com
Mon, 27 Jul 2026 07:00:00 GMTGossamer regains rights to lung disease asset from Chiesi after Phase 3 fail - BioSpace

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Chiesi.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.